ST海越(600387.SH):海越資管擬出資3000萬元參投武漢天堂硅谷恆新創業投資基金
格隆匯11月1日丨ST海越(600387.SH)公佈,2021年11月1日,公司全資子公司海越資管因發展需要,與天堂硅谷資產管理集團有限公司(普通合夥人)(“天堂硅谷”)和其他5名有限合夥人簽訂了《武漢天堂硅谷恆新創業投資基金合夥企業(有限合夥)有限合夥協議》。海越資管擬出資人民幣3000萬元,作為有限合夥人參與投資。截至公吿日,合夥企業認繳出資總額為37500萬元。
該合夥制私募投資基金為權益類產品,主要投向信息技術、智能製造、醫療健康、大消費等重點行業的非上市公司股權,重點投資於成長期、成熟期及擬IPO企業,並預期通過被投企業上市、股權轉讓等方式實現投資收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.